In a five-year retrospective clinical study conducted at Dr. Smile Medical Group in Shanghai and Beijing Vein Centers, comparing varicose vein treatments, CHIVA (Cure Conservatrice et Hémodynamique de l’Insuffisance Veineuse en Ambulatoire) emerges as a potential game-changer, offering new hope for patients seeking lasting relief.
CHIVA Outshines Endovenous Laser and Radiofrequency Methods
While endovenous laser and radiofrequency treatments have been mainstays, the study reveals a significant difference in recurrence rates over five years. CHIVA, a minimally invasive approach focusing on venous hemodynamics, boasts an impressive 4% recurrence rate compared to 27% in the endovenous laser group and 21% in the radiofrequency group.
Patient-Friendly, Lasting Results
CHIVA’s Potential as a Long-Term Solution
The study showcases CHIVA’s potential as a long-term solution for managing varicose veins. With a focus on preserving veins and addressing specific aspects of venous pathology, CHIVA stands out with remarkably lower overall recurrence rates, especially in AASV reflux. This suggests that CHIVA might be a preferred choice for patients seeking lasting relief.
Navigating the Complexities of CHIVA Implementation
While CHIVA demonstrates promise, its successful implementation depends on the expertise of healthcare providers. Challenges arise in the training of medical professionals in this intricate technique. Given its emphasis on venous hemodynamics and the need for precise interventions, CHIVA requires specialized skills that not all practitioners possess.
Refinement and Ongoing Research for CHIVA Adoption
The study underscores the importance of ongoing research and refinement in CHIVA training. Challenges include the need for specialized skills in duplex ultrasound assessments, dynamic evaluations, and precise intervention planning. As CHIVA gains recognition, efforts are underway to develop standardized training programs and guidelines.